The use of lisuride in the treatment of multiple system atrophy with autonomic failure (Shy-Drager syndrome).

In a controlled trial lisuride, an ergolene derivative with dopamine receptor agonist properties was given maximum tolerated doses (2.4 mg/day) to seven patients with multiple system atrophy with autonomic failure (Shy-Drager syndrome). Improvement in Parkinsonian features occurred in only one patie...

Volledige beschrijving

Bibliografische gegevens

Gepubliceerd in:	J Neurol Neurosurg Psychiatry
Hoofdauteurs:	Lees, A J, Bannister, R
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	BMJ Publishing Group 1981
Onderwerpen:	Research Article
Online toegang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC490960/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7241162/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.44.4.347
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!